CHMP recommends eight Big Pharma drug label extensions
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended label extensions to eight drugs all from major pharmaceutical companies, including Novartis, Bayer, Johnson & Johnson, GlaxoSmithKline and Eisai.